Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
04/2010
04/27/2010CA2303202C Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
04/27/2010CA2293692C Methods and reagents for vaccination which generate a cd8 t cell immune response
04/27/2010CA2278465C Diagnosis and treatment of myocardial failure
04/27/2010CA2245379C Superpotent calcitonin analogs having greatly increased hypocalcemic action in vivo
04/27/2010CA2222129C A method for producing influenza hemagglutinin multivalent vaccines
04/27/2010CA2210242C Production of enzymatically active recombinant carboxypeptidase b
04/27/2010CA2203758C Compositions for the detection of proteases in biological samples and methods of use thereof
04/27/2010CA2195653C Cells bearing cd4 decoy receptors and related molecules and methods
04/27/2010CA2179909C Ligand that binds fas antigen
04/27/2010CA2162353C Interferon-.gamma. production inducing polypeptide, monoclonal antibody, and agent for interferon-.gamma. susceptive disease
04/22/2010WO2010045648A2 Methods for removing nicotine and other alkaloids from soluble leaf proteins in solanaceous and other plant species
04/22/2010WO2010045613A1 Immunoenhancer-linked oligomeric hiv vaccines
04/22/2010WO2010045589A2 Optimizing erythropoietin therapy
04/22/2010WO2010045586A2 Muc-1 cytoplasmic domain peptides as inhibitors of cancer
04/22/2010WO2010045342A1 Method of making biologically active alpha-beta peptides
04/22/2010WO2010045335A1 Transducible polypeptides for modifying mitochondrial metabolism
04/22/2010WO2010045324A1 Utilization of fatty acid desaturases from hemiselmis spp.
04/22/2010WO2010045261A1 Single chain fc type iii interferons and methods of using same
04/22/2010WO2010044894A1 Methods and compositions for treatment of myotonic dystrophy
04/22/2010WO2010044786A1 Modified variant bowman birk protease inhibitors
04/22/2010WO2010044691A1 Immunosuppressive peptide
04/22/2010WO2010044464A1 Modified amyloid beta peptide
04/22/2010WO2010043977A2 Dengue virus neutralizing antibodies and uses thereof
04/22/2010WO2010043972A2 Pharmaceutical compositions and methods of use for the prevention and treatment of hypoxic injury
04/22/2010WO2010043928A1 Derived proteins from cry genes of bacillus thuringiensis
04/22/2010WO2010043842A1 Staphylococcus protein essential for growth
04/22/2010WO2010043520A1 Hydrophobin solution containing antifoam
04/22/2010WO2010043444A2 Pharmaceutical preparation for the treatment and/or prevention of ischemia/reperfusion injury and the sequels thereof
04/22/2010WO2010043232A1 Potato virus a coat protein-based vaccine for treating melanoma and its use
04/22/2010WO2010043230A1 Multiligand constructs
04/22/2010WO2010043073A1 Collagen polypeptide, preparation method and uses thereof
04/22/2010WO2010043057A1 Bsa-specific antibodies
04/22/2010WO2010043049A1 Etoposide and doxorubicin conjugates for drug delivery
04/22/2010WO2010043047A1 Conjugates of glp-1 agonists and uses thereof
04/22/2010WO2010043046A1 Peptide inhibitors of type iii secretion
04/22/2010WO2010025173A3 Labeled peptides and methods of use thereof for improved oxidation and mapping of disulfide bridges
04/22/2010WO2010017209A3 Membrane proximal region of hiv gp41 anchored to the lipid layer of a virus-like particle vaccine
04/22/2010WO2010015938A3 Use of agonists of integrin alpha 5 for inducing the osteogenic differentiation of mesenchymal stem cells
04/22/2010WO2010014708A3 Factor viii polymer conjugates
04/22/2010WO2010012760A3 Plants having modified growth characteristics and a method for making the same
04/22/2010WO2010011960A3 Triple acting antimicrobials that are refractory to resistance development
04/22/2010WO2010011284A3 Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides
04/22/2010WO2010007622A3 Long-acting interferons and derivatives thereof and methods thereof
04/22/2010WO2010003766A3 Multimeric tnf receptors
04/22/2010WO2010002583A3 Natriuretic polypeptides with unique pharmacologic profiles
04/22/2010WO2010000708A3 Promoters from brassica napus for seed specific gene expression
04/22/2010WO2009158618A3 Avian reoviridae
04/22/2010WO2009145944A3 Thermophilic and thermoacidophilic sugar transporter genes and enzymes from alicyclobacillus acidocaldarius and related organisms
04/22/2010WO2009138466A3 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
04/22/2010WO2009132401A3 Citrullinated cytokines
04/22/2010WO2009039414A8 Methods and compositions for detection of ehrlichia chaffeensis (vlpt)
04/22/2010WO2009029601A3 Receptor-targeting reagents
04/22/2010WO2008047241A3 Modified corticotropin releasing factor peptides and uses thereof
04/22/2010US20100100981 Wuschel (wus) gene homologs
04/22/2010US20100100979 Biomarker specific for cancer
04/22/2010US20100100976 Methods and compositions related to apobec-1 expression
04/22/2010US20100099855 Recombinant protein comprising starch binding domain and use thereof
04/22/2010US20100099853 Multivalent Antibody Constructs
04/22/2010US20100099852 Systems, methods, and compositions for prevention of tissue adhesion
04/22/2010US20100099851 Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same
04/22/2010US20100099850 Human cytokine receptor
04/22/2010US20100099849 Interleukin-17 receptor homologue
04/22/2010US20100099848 Rankl production inhibitor
04/22/2010US20100099845 Protected enantiopure trifluorothreonines and methods of making and using same
04/22/2010US20100099844 Hydrophobin Solution Containing Antifoam
04/22/2010US20100099649 Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adducts
04/22/2010US20100099629 Ophthalmological composition
04/22/2010US20100099626 Cell penetrating peptides for intracellular delivery of molecules
04/22/2010US20100099623 Cross-Linked Collagen and Uses Thereof
04/22/2010US20100099620 Protracted GLP-1 Compositions
04/22/2010US20100099619 Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
04/22/2010US20100099618 Interleukin-9 and Interleukin-4 Chimeric Antagonist Muteins and Methods of Using Same
04/22/2010US20100099617 Secreted proteins
04/22/2010US20100099615 Pancreatic regenerating protein i in chronic pancreatitis and aging implications for new therapeutic approaches to diabetes
04/22/2010US20100099614 Antimicrobial Peptides and Methods of Use
04/22/2010US20100099613 Peptides for inducing a ctl and/or htl response to hepatitis c virus
04/22/2010US20100099607 Casein complexes
04/22/2010US20100099601 Fibrillation-resistant insulin and insulin analogues
04/22/2010US20100099575 Novel polypeptide scaffolds and use thereof
04/22/2010US20100099185 Method of making biologically active alpha-beta peptides
04/22/2010US20100099184 Polynucleotides encoding class ii cytokine receptor-7
04/22/2010US20100099182 System for monitoring the location of transgenes
04/22/2010US20100099168 Fibronectin type III (Fn3) for use as diagnostic and treatment tools in gene therapy; identifying the amino acid sequence of a polypeptide molecule capable of binding to a specific binding partner (SBP) so as to form a polypeptide:SSP complex
04/22/2010US20100099153 Method for producing L-amino acids using bacteria belonging to the genus escherichia
04/22/2010US20100099148 Novel Vectors for Production of Antibodies
04/22/2010US20100099144 Combined use of cell permeable nanog and oct4 for increasing self-renewal and suppressing differentiation of stem cells
04/22/2010US20100099113 Minimized small peptides with high affinity for factor viii and factor viii-like proteins
04/22/2010US20100099111 Antibodies against a protein entitled 161p2f10b
04/22/2010US20100099105 Antibodies having binding specificity for the extracellular domain of a breast cancer resistance protein (bcrp)
04/22/2010US20100099081 Method for Typing HLA Alleles
04/22/2010US20100098924 Collagen membrane for medical use and method for manufacturing the same
04/22/2010US20100098729 Novel surface exposed immunoglobulin d-binding protein from foraxella catarrhalis
04/22/2010US20100098723 Vaccine compositions against infectious pathologies for mammals
04/22/2010US20100098722 Packaging of Immunostimulatory Substances Into Virus-Like Particles: Method of Preparation and Use
04/22/2010US20100098718 Nucleic acid vectors for immunization
04/22/2010US20100098713 Drug screening; assay for aldehyde dehydrogenase activity; cancer
04/22/2010US20100098703 Determination of am-binding proteins and the association of adrenomedullin (am) therewith
04/22/2010US20100098697 Chlamydia trachomatis antigens
04/22/2010US20100098695 Biomarker specific to brain/nerve or specific to neuronal differentiation
04/22/2010US20100098684 Biomarkers and methods for detecting and treating spinal and joint pain
1 ... 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 ... 2916